- Published on
Emergency and Acute Medicine – Toxoplasmosis
Emergency and Acute Medicine – Toxoplasmosis
Toxoplasmosis is an infection caused by Toxoplasma gondii, an intracellular protozoan that exists in three forms: tachyzoites (actively replicating), tissue cysts (chronic latent form), and oocysts (shed in cat feces). Transmission occurs primarily through ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with oocysts, or contact with cat feces or contaminated soil. Less common routes include transplacental transmission, blood transfusion, and organ transplantation.
Toxoplasmosis is extremely common worldwide, with approximately 70% of adults demonstrating prior exposure. Most immunocompetent individuals remain asymptomatic. Cats serve as the definitive host, and the incubation period typically ranges from 4 to 21 days.
Clinical manifestations vary depending on the host’s immune status and the type of infection. In immunocompromised patients, particularly those with HIV/AIDS, toxoplasmosis most commonly presents as encephalitis. Symptoms are typically subacute and include headache, fever, altered mental status, seizures, cranial nerve deficits, and focal neurologic signs. Neuropsychiatric symptoms such as psychosis, paranoia, or dementia may also occur. Pulmonary involvement may present as pneumonitis with dyspnea and nonproductive cough.
In immunocompetent individuals, approximately 90% of infections are asymptomatic. When symptoms occur, they usually present as a self-limited mononucleosis-like illness with cervical lymphadenopathy, fever, malaise, sore throat, and occasionally hepatosplenomegaly or rash. Rarely, severe complications such as encephalitis or pneumonitis may occur.
Ocular toxoplasmosis is an important manifestation, often presenting with blurred vision, scotoma, pain, and photophobia. Examination may reveal chorioretinitis with characteristic yellow-white retinal lesions. This form is particularly common in individuals with untreated congenital infection and may lead to long-term visual impairment.
Congenital toxoplasmosis results from maternal infection during pregnancy. Infection during the first trimester is associated with severe outcomes such as miscarriage or stillbirth, while later infections are more likely to be transmitted to the fetus but may present with delayed manifestations. Many affected infants are asymptomatic at birth but later develop neurologic or ocular complications, including blindness, seizures, or developmental delay.
Diagnosis involves a combination of clinical suspicion and laboratory testing. Detection of the organism may be achieved through analysis of blood, cerebrospinal fluid, bronchoalveolar lavage, or amniotic fluid. Serologic testing for IgM and IgG antibodies is commonly used, although interpretation can be challenging due to false positives and negatives. Imaging plays a key role in CNS disease: CT or MRI typically shows multiple bilateral ring-enhancing lesions. Chest radiography may reveal a reticulonodular pattern in pulmonary involvement.
The differential diagnosis includes Cryptococcal meningitis, Primary CNS lymphoma, Pneumocystis pneumonia, Cytomegalovirus retinitis, and mycobacterial infections, particularly in immunocompromised patients.
Management depends on disease severity and host immune status. Immunocompetent patients with mild disease typically require no treatment. Symptomatic or severe cases are treated with a combination of pyrimethamine, sulfadiazine, and folinic acid, or alternatively clindamycin in patients with sulfa allergy.
Immunocompromised patients require prompt and aggressive therapy, often initiated empirically when characteristic brain lesions are present. Treatment typically continues for 4–6 weeks after symptom resolution, and long-term prophylaxis may be necessary, particularly in patients with HIV.
Ocular disease is treated similarly, often with the addition of corticosteroids in cases involving the macula or optic nerve. In pregnancy, management is complex and requires specialist consultation; spiramycin is typically used early in pregnancy to reduce fetal transmission risk.
Patients with severe systemic disease, CNS involvement, or immunocompromise require hospital admission. Immunocompetent patients with mild disease can usually be managed as outpatients with follow-up.
Key clinical pearls include recognizing that toxoplasmosis is often asymptomatic in healthy individuals but can cause life-threatening disease in immunocompromised patients. CNS toxoplasmosis should always be suspected in patients with HIV presenting with focal neurologic deficits and ring-enhancing brain lesions. Prevention, particularly in pregnant women, includes avoiding undercooked meat and exposure to cat litter or contaminated soil.
Emergency and Acute Medicine – Toxoplasmosis
Toxoplasmosis is an infection caused by Toxoplasma gondii, an intracellular protozoan that exists in three forms: tachyzoites (actively replicating), tissue cysts (chronic latent form), and oocysts (shed in cat feces). Transmission occurs primarily through ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with oocysts, or contact with cat feces or contaminated soil. Less common routes include transplacental transmission, blood transfusion, and organ transplantation.
Toxoplasmosis is extremely common worldwide, with approximately 70% of adults demonstrating prior exposure. Most immunocompetent individuals remain asymptomatic. Cats serve as the definitive host, and the incubation period typically ranges from 4 to 21 days.
Clinical manifestations vary depending on the host’s immune status and the type of infection. In immunocompromised patients, particularly those with HIV/AIDS, toxoplasmosis most commonly presents as encephalitis. Symptoms are typically subacute and include headache, fever, altered mental status, seizures, cranial nerve deficits, and focal neurologic signs. Neuropsychiatric symptoms such as psychosis, paranoia, or dementia may also occur. Pulmonary involvement may present as pneumonitis with dyspnea and nonproductive cough.
In immunocompetent individuals, approximately 90% of infections are asymptomatic. When symptoms occur, they usually present as a self-limited mononucleosis-like illness with cervical lymphadenopathy, fever, malaise, sore throat, and occasionally hepatosplenomegaly or rash. Rarely, severe complications such as encephalitis or pneumonitis may occur.
Ocular toxoplasmosis is an important manifestation, often presenting with blurred vision, scotoma, pain, and photophobia. Examination may reveal chorioretinitis with characteristic yellow-white retinal lesions. This form is particularly common in individuals with untreated congenital infection and may lead to long-term visual impairment.
Congenital toxoplasmosis results from maternal infection during pregnancy. Infection during the first trimester is associated with severe outcomes such as miscarriage or stillbirth, while later infections are more likely to be transmitted to the fetus but may present with delayed manifestations. Many affected infants are asymptomatic at birth but later develop neurologic or ocular complications, including blindness, seizures, or developmental delay.
Diagnosis involves a combination of clinical suspicion and laboratory testing. Detection of the organism may be achieved through analysis of blood, cerebrospinal fluid, bronchoalveolar lavage, or amniotic fluid. Serologic testing for IgM and IgG antibodies is commonly used, although interpretation can be challenging due to false positives and negatives. Imaging plays a key role in CNS disease: CT or MRI typically shows multiple bilateral ring-enhancing lesions. Chest radiography may reveal a reticulonodular pattern in pulmonary involvement.
The differential diagnosis includes Cryptococcal meningitis, Primary CNS lymphoma, Pneumocystis pneumonia, Cytomegalovirus retinitis, and mycobacterial infections, particularly in immunocompromised patients.
Management depends on disease severity and host immune status. Immunocompetent patients with mild disease typically require no treatment. Symptomatic or severe cases are treated with a combination of pyrimethamine, sulfadiazine, and folinic acid, or alternatively clindamycin in patients with sulfa allergy.
Immunocompromised patients require prompt and aggressive therapy, often initiated empirically when characteristic brain lesions are present. Treatment typically continues for 4–6 weeks after symptom resolution, and long-term prophylaxis may be necessary, particularly in patients with HIV.
Ocular disease is treated similarly, often with the addition of corticosteroids in cases involving the macula or optic nerve. In pregnancy, management is complex and requires specialist consultation; spiramycin is typically used early in pregnancy to reduce fetal transmission risk.
Patients with severe systemic disease, CNS involvement, or immunocompromise require hospital admission. Immunocompetent patients with mild disease can usually be managed as outpatients with follow-up.
Key clinical pearls include recognizing that toxoplasmosis is often asymptomatic in healthy individuals but can cause life-threatening disease in immunocompromised patients. CNS toxoplasmosis should always be suspected in patients with HIV presenting with focal neurologic deficits and ring-enhancing brain lesions. Prevention, particularly in pregnant women, includes avoiding undercooked meat and exposure to cat litter or contaminated soil.
0 Comments
